Ravin Ratan

2.0k total citations
54 papers, 563 citations indexed

About

Ravin Ratan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ravin Ratan has authored 54 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Ravin Ratan's work include Sarcoma Diagnosis and Treatment (35 papers), Soft tissue tumor case studies (11 papers) and Cardiac tumors and thrombi (11 papers). Ravin Ratan is often cited by papers focused on Sarcoma Diagnosis and Treatment (35 papers), Soft tissue tumor case studies (11 papers) and Cardiac tumors and thrombi (11 papers). Ravin Ratan collaborates with scholars based in United States, United Kingdom and Germany. Ravin Ratan's co-authors include Shreyaskumar Patel, Christina L. Roland, Andrew J. Bishop, Wei‐Lien Wang, Neeta Somaiah, Alexander J. Lazar, Maria A. Zarzour, Joseph A. Ludwig, Dejka M. Araujo and B. Ashleigh Guadagnolo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ravin Ratan

47 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravin Ratan United States 14 368 240 129 112 93 54 563
Élisabeth Longchampt France 13 408 1.1× 198 0.8× 86 0.7× 91 0.8× 148 1.6× 38 657
Emanuela Virdis Italy 8 433 1.2× 152 0.6× 60 0.5× 230 2.1× 129 1.4× 10 589
Teruto Isayama Japan 16 433 1.2× 216 0.9× 96 0.7× 214 1.9× 111 1.2× 34 624
Jun Nishio Japan 18 702 1.9× 249 1.0× 160 1.2× 348 3.1× 189 2.0× 70 917
Yoshinori Imura Japan 14 289 0.8× 195 0.8× 62 0.5× 103 0.9× 120 1.3× 51 471
Xin Sun China 13 451 1.2× 281 1.2× 70 0.5× 152 1.4× 181 1.9× 63 706
Marie‐Pierre Castex France 11 212 0.6× 81 0.3× 51 0.4× 70 0.6× 100 1.1× 23 362
Camille Schiffler France 10 251 0.7× 152 0.6× 55 0.4× 59 0.5× 87 0.9× 24 385
Jean‐François Goussot France 7 323 0.9× 221 0.9× 122 0.9× 106 0.9× 37 0.4× 9 472
Mihaela Druta United States 14 255 0.7× 252 1.1× 56 0.4× 63 0.6× 63 0.7× 43 437

Countries citing papers authored by Ravin Ratan

Since Specialization
Citations

This map shows the geographic impact of Ravin Ratan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravin Ratan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravin Ratan more than expected).

Fields of papers citing papers by Ravin Ratan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravin Ratan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravin Ratan. The network helps show where Ravin Ratan may publish in the future.

Co-authorship network of co-authors of Ravin Ratan

This figure shows the co-authorship network connecting the top 25 collaborators of Ravin Ratan. A scholar is included among the top collaborators of Ravin Ratan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravin Ratan. Ravin Ratan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ratan, Ravin, Bernd Kasper, Thierry Alcindor, et al.. (2025). Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial. Journal of Clinical Oncology. 43(34). 3646–3651.
2.
3.
4.
Kasper, Bernd, Christina Baumgarten, Ravin Ratan, et al.. (2025). A study to learn if nirogacestat works and is safe for adult participants with desmoid tumors: a plain language summary of the DeFi study. Future Oncology. 21(8). 889–901. 1 indexed citations
5.
Meyers, Paul A., Noah Federman, Najat C. Daw, et al.. (2024). Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. Journal of Clinical Oncology. 42(31). 3725–3734. 13 indexed citations
6.
Chiang, Yi‐Ju, Anthony P. Conley, Dejka M. Araujo, et al.. (2024). Systemic therapy in NF-1 associated malignant peripheral nerve sheath tumors (MPNST).. Journal of Clinical Oncology. 42(16_suppl). 11583–11583. 1 indexed citations
7.
Yevich, Steven, J. Kuban, Alda L. Tam, et al.. (2024). Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver. Cancer. 130(15). 2703–2712. 5 indexed citations
8.
9.
Denu, Ryan A., Davis R. Ingram, Khalida Wani, et al.. (2024). DNA mismatch repair deficiency as a biomarker in sarcoma. PubMed. 1(4). 100091–100091.
10.
Fellman, Bryan, Larissa A. Meyer, Nicole D. Fleming, et al.. (2024). Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study. Gynecologic Oncology. 191. 143–149. 1 indexed citations
11.
Truong, Danh D., Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, et al.. (2023). Abstract 1196: The epigenetic impact and therapeutic opportunity of AR-directed therapy for DSRCT. Cancer Research. 83(7_Supplement). 1196–1196. 1 indexed citations
12.
Kasper, Bernd, Mrinal M. Gounder, Rashmi Chugh, et al.. (2023). 1929P phase II results from the RINGSIDE phase II/III trial of AL102 for treatment of desmoid tumors. Annals of Oncology. 34. S1037–S1037. 2 indexed citations
13.
Subbiah, Vivek, Irene Braña, Alessandra Longhi, et al.. (2022). Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study. Clinical Cancer Research. 28(13). 2762–2770. 18 indexed citations
14.
Boyce-Fappiano, David, Ahsan Farooqi, Devarati Mitra, et al.. (2022). Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Advances in Radiation Oncology. 7(3). 100913–100913. 18 indexed citations
15.
Gounder, Mrinal M., Priscilla Merriam, Ravin Ratan, et al.. (2020). Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer. 127(8). 1311–1317. 12 indexed citations
16.
Tarek, Nidale, Rabih Said, Clark R. Andersen, et al.. (2020). Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers. 12(10). 2927–2927. 12 indexed citations
17.
Ludwig, Joseph A., Noah Federman, Peter M. Anderson, et al.. (2020). 1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma. Annals of Oncology. 31. S972–S972. 10 indexed citations
18.
Bishop, Andrew J., Maria A. Zarzour, Ravin Ratan, et al.. (2018). Long-Term Outcomes for Patients With Desmoid Fibromatosis Treated With Radiation Therapy: A 10-Year Update and Re-evaluation of the Role of Radiation Therapy for Younger Patients. International Journal of Radiation Oncology*Biology*Physics. 103(5). 1167–1174. 19 indexed citations
19.
Ratan, Ravin & Shreyaskumar Patel. (2017). Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?. Current Treatment Options in Oncology. 18(6). 34–34. 14 indexed citations
20.
Srivastava, Sanjeev Kumar, et al.. (2000). Report on Revised National Tuberculosis Control Programme : urban pilot project in Lucknow.. Indian Journal of Tuberculosis. 47(3). 159–162. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Élisabeth Longchampt Breakdown of academic impact, for papers by Emanuela Virdis Breakdown of academic impact, for papers by Teruto Isayama Breakdown of academic impact, for papers by Jun Nishio Breakdown of academic impact, for papers by Yoshinori Imura Breakdown of academic impact, for papers by Xin Sun Breakdown of academic impact, for papers by Marie‐Pierre Castex Breakdown of academic impact, for papers by Camille Schiffler Breakdown of academic impact, for papers by Jean‐François Goussot Breakdown of academic impact, for papers by Mihaela Druta
Rankless by CCL
2026